US’s Battle against COVID-19 & Roles of Healthcare System and Businesses in Policy Outcomes
Aug 18, 2020 (9:00 AM - 10:30 AM) (GMT+8)
Phase 1, Session 1 of Program Series: Continuing US-China Regulatory Dialogues for Better Healthcare
This event is brought to you by
Dr. Sten Vermund, Dean and Anna M.R. Lauder Professor of Public Health; Professor of Pediatrics, Yale School of Medicine at Yale University
Dr. Sten Vermund is a pediatrician and infectious disease epidemiologist focused on diseases of low and middle income countries. His work on HIV-HPV interactions among women in Bronx methadone programs motivated a change in the 1993 CDC AIDS case surveillance definition and inspired cervical cancer screening programs launched within HIV/AIDS programs around the world. The thrust of his research has focused on health care access, adolescent sexual and reproductive health and rights, and prevention of HIV transmission among general and key populations, including mother-to-child. Dr. Vermund has become increasingly engaged in health policy, particularly around sustainability of HIV/AIDS programs and their expansion to non-communicable diseases, pandemic respiratory disease response and prevention, and public health workforce development. Since the advent of the novel coronavirus, his work has engaged colleagues in China and Connecticut for pandemic response.
Education & Training:
PhD Columbia University, Epidemiology (1990)
MPhil Columbia University, Epidemiology (1987)
MSc London School of Hygiene and Tropical Medicine,
Community Health in Developing Countries (1981)
DPH Royal Institute of Public Health and Hygiene,
Public Health (1981)
MD Yeshiva University,
Albert Einstein College of Medicine (1977)
BA Stanford University, Human Biology (1974)
Mellon Foundation Fellowship Columbia University
Fellow in Clinical Epidemiology Columbia-Presbyterian
Medical Center
Pediatrics Internship and Residency Presbyterian (Babies) Hospital
Research Interests:
Environment and Public Health; HIV; Public Health; Global Health; Women's Health; Child Health
Public Health Interests:
Global Health; Climate Change; HIV/AIDS; Infectious Diseases; Women's Health; Child/Adolescent Health; COVID-19
Departments & Organizations:
Cancer Microbiology; Epidemiology of Microbial Diseases; Yale Cancer Center; Yale Institute for Global Health; Yale School of Public Health; Yale University; Yale-UPR Integrated HIV Basic and Clinical Sciences Initiative; YSPH Global Health Concentration
ACTIVITIES:
HIV Phylogeny
Nur-Sultan, Kazakhstan (2020-2021)
NIH R03
HIV implementation and prevention science research:
Lusaka, Zambia; Maputo, Mozambique; Khartoum, Sudan; N'Djamena, Chad; Bengaluru, India; Shanghai, China; Johannesburg, South Africa; Lima, Peru; Karachi, Pakistan; Kingston, Jamaica 2017
Event Details
SESSION TOPIC:
Beyond myths and battles between media and the White House:
What worked and what did not in the U.S.'s battle against COVID-19?
And what roles have the healthcare system and businesses played to drive policy outcomes – wins and losses?
This session is part of the program series:
Continuing US-China Regulatory Dialogues for Better Healthcare
Reflecting on the recent pandemic experience, lessons and beyond
(For detailed program information, please click here to download.)
Phase I. Facts that matter: Getting a holistic view on the immediate and mid-/long term policy and scientific efforts in response to the COVID-19 pandemic in the US and China
Timeline: August to September, 2020
This phase of programs will focus on discovering the facts and developing the issue bases of all the emergency measures the U.S. and Chinese governments have taken to combat Covid-19 in the healthcare and public health contexts, and provide a holistic outlook into future economic and industrial policies that affect scientific research, regulatory development, business and investment trends, and education and training. These discussions will be delivered through four informative online lectures.
*This is an online event, and meeting access will be sent to approved registrants only.
*While sponsorship is not required, we are open to discuss customized sponsorship opportunities and benefits.
Alan Beebe is President of the American Chamber of Commerce in China based in Beijing. He has over twenty-five years of business experience in Asia, i...
Co-Chair of AmCham China Healthcare Forum; CEO at United Family Healthcare
Roberta Lipson is the Co-Chair of AmCham China Healthcare Forum, CEO and founder of United Family Healthcare (UFH). She has over 40 years of experienc...
Co-Chair of AmCham China Healthcare Forum; Vice President at Johnson & Johnson China
Jeffrey Que is the Co-Chair of AmCham China Healthcare Forum, Member of China President Council and Vice President in Johnson & Johnson China. Jeffre...